The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Processa Pharmaceuticals Inc’s current trading price is -81.43% away from its 52-week high, while its distance from the 52-week low is 130.98%. The stock’s price range for this period has been between $0.18 and $2.24 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.69 million for the day, a number notably lower than the average daily volume of 2.03 million over the last three months.
The present stock price for Processa Pharmaceuticals Inc (PCSA) is $0.42. In the last trading session, the stock made a considerable jump, reaching $0.45 after an opening price of $0.4198. The stock briefly fell to $0.4075 before ending the session at $0.39.
In terms of market performance, Processa Pharmaceuticals Inc had a fairly uneven. The highest value for the stock in the past year was $2.24 on 12/15/22, and the lowest value was recorded at $0.18 on 10/06/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Processa Pharmaceuticals Inc (PCSA) has experienced a quarterly rise of 10.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 10.25M and boasts a workforce of 15 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3717, with a change in price of -0.0965. Similarly, Processa Pharmaceuticals Inc recorded 1,349,942 in trading volume during the last 100 days, posting a change of -18.83%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PCSA stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
PCSA Stock Stochastic Average
Processa Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 32.77%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 83.72%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 59.34% and 44.18%, respectively.
PCSA Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -62.18% this year. Over the last six months, there has been a stronger performance of -36.97%. The price of PCSA leaped by -23.82% during the last 30 days period. For the last 5-days stocks have improved 30.82%.